RXST vs TCMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 05, 2026

RXST

37.7
AI Score
VS
RXST Wins

TCMD

34.2
AI Score

Investment Advisor Scores

RXST

38score
Recommendation
AVOID NEW MONEY

TCMD

34score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric RXST TCMD Winner
Forward P/E 116.2791 19.1205 TCMD
PEG Ratio 0 17.792 Tie
Revenue Growth 0.3% 7.1% TCMD
Earnings Growth 0.0% -13.9% RXST
Tradestie Score 37.7/100 34.2/100 RXST
Profit Margin -36.8% 6.7% TCMD
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

RXST 1M: +8.2% · 3M: -30.1% TCMD 1M: +20.1% · 3M: +13.0%

Current Technical Phase

RXST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.4 · Price: $4.90

TCMD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.2 · Price: $26.80

Fundamentals Snapshot

Metric RXST TCMD
Market Cap — —
Forward P/E -6.8 18.1
Trailing P/E — 25.8
Revenue (TTM) — —
Revenue Growth -0.2% 0.1%
Gross Margin 0.8% 0.8%
Operating Margin -0.8% 0.1%
EPS -1.29 1.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXST is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.